John Maraganore, Alnylam CEO (Ryan Emberley/Getty Images for Klick Inc.)

John Maraganore makes a bold promise ahead of #JPM21 — aim­ing to take Al­ny­lam in­to the ranks of biotech's best

Al­ny­lam CEO John Maraganore is a big fan of five-year plans, and with JPM21 kick­ing off this week, he re­vealed his com­pa­ny’s newest am­bi­tious goal …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.